Total liabilities · 2012–2025
Niagen Bioscience total liabilities
$29.9M+34.7% · FY2025
Niagen Bioscience (NAGE) reported $29.9M in total liabilities for fiscal 2025, +34.7% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $29.9M | +34.7% | Open → |
| FY20242024-12-31 | $22.2M | −16.3% | Open → |
| FY20232023-12-31 | $26.5M | +4.4% | Open → |
| FY20222022-12-31 | $25.4M | −2.8% | Open → |
| FY20212021-12-31 | $26.1M | +19.1% | Open → |
| FY20202020-12-31 | $21.9M | +10.8% | Open → |
| FY20192019-12-31 | $19.8M | +31.5% | Open → |
| FY20182018-12-31 | $15.1M | +69.3% | Open → |
| FY20172017-12-30 | $8.9M | −9.1% | Open → |
| FY20162016-12-31 | $9.8M | −27.4% | Open → |
| FY20152016-01-02 | $13.5M | +79.2% | Open → |
| FY20142015-01-03 | $7.5M | +126.4% | Open → |
| FY20132013-12-28 | $3.3M | −34.1% | Open → |
| FY20122012-12-29 | $5.0M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2012–2025 compound annual growth +14.7%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Niagen Bioscience total liabilities |url=https://companiesranked.com/en/company/niagen-bioscience/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Niagen Bioscience total liabilities. CompaniesRanked. https://companiesranked.com/en/company/niagen-bioscience/total-liabilitiesBibTeX
@misc{companiesranked-en-company-niagen-bioscience-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Niagen Bioscience total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/niagen-bioscience/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001386570-26-000043 · August 4, 2026
{{cite web |title=Niagen Bioscience total liabilities — 10-Q (0001386570-26-000043) |url=https://www.sec.gov/Archives/edgar/data/1386570/000138657026000043/cdcx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-04}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.